Status:

COMPLETED

5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors

Lead Sponsor:

University of Turin, Italy

Conditions:

Neuroendocrine Tumors

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Well differentiated neuroendocrine carcinomas have low proliferative activity and conventional chemotherapy is not recommended. Metronomic chemotherapy, i.e. the frequent administration of cytotoxic d...

Detailed Description

Metastatic or locally advanced well differentiated neuroendocrine carcinoma were treated with 5Fluorouracil protracted intravenous infusion (200 mg/m2 daily) plus Octreotide LAR (20 mg monthly). Prim...

Eligibility Criteria

Inclusion

  • histological diagnosis of well-differentiated neuroendocrine carcinoma according to the World Health Organization (WHO) classification;
  • locally advanced or metastatic disease not amenable to surgery with radical intent;
  • at least one measurable target lesion;
  • radiological documentation of progressive disease;
  • ECOG performance status grade \<=2;
  • life expectancy \>12 weeks;
  • adequate bone marrow reserve;
  • adequate hepatic and renal function;
  • ability to comply with the protocol procedures (including geographic accessibility);
  • written informed consent.

Exclusion

  • non-malignant systemic disease or conditions that precluded patients from receiving the study therapy;
  • second primary malignancies and previous systemic antineoplastic treatment including somatostatin analogues;
  • history of prior malignancy, excepted for cured non-melanoma skin cancer, and cured in situ cervical carcinoma.

Key Trial Info

Start Date :

February 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2006

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT00953394

Start Date

February 1 2002

End Date

December 1 2006

Last Update

August 6 2009

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Federico Castiglione

Alba, Cuneo, Italy, 12051

2

Davide Perroni

Saluzzo, Cuneo, Italy, 12037

3

Benedetta Ferretti

San Severino Marche, Macerata, Italy, 62027

4

Sebastiano Bombaci

Ivrea, Torino, Italy, 10015